HBx, a small regulatory protein of hepatitis B virus, plays an important role in stimulating viral genome replication. HBx was shown to be associated with diverse subcellular locations, such as the nucleus, cytoplasm and mitochondria. Some studies have linked the stimulation of genome replication by HBx to its cytoplasmic function, while other reports have attributed this function to its nuclear component. To clarify this discrepancy, we measured viral genome replication by complementing an HBx-null replicon in two different ways: by (i) co-transfecting with an increasing amount of HBx expression plasmid and (ii) co-transfecting with re-targeted variants of HBx that are confined to either the nucleus or the cytoplasm due to either the nuclear localization signal (NLS) or the nuclear export signal (NES) tags, respectively. Intriguingly, immunostaining analysis indicated that the subcellular localization of HBx is primarily influenced by its abundance; HBx is confined to the nucleus at low levels but is usually detected in the cytoplasm at high levels. Importantly, HBx, whether re-targeted by either the NLS or NES tag, stimulates viral genome replication to a level comparable to that of the wild-type. Furthermore, similar to the wild-type, the stimulation of viral genome replication by the re-targeted HBx occurred at the transcription level. Thus, we concluded that the stimulation of viral genome replication by HBx is linked to both nuclear and cytoplasmic HBx, although the underlying mechanism of stimulation most likely differs.
INTRODUCTION
Hepatitis B virus (HBV) is the prototypic member of the hepadnavirus family and is a major cause of liver disease worldwide, ranging from acute and chronic hepatitis to liver cirrhosis and hepatocellular carcinoma (HCC) (Seeger et al., 2007) . Other members of this virus family include woodchuck hepatitis virus and more distantly related avian viruses, such as the duck hepatitis B virus (Seeger et al., 2007) . Mammalian, but not avian, hepadnaviruses have been associated with development of HCC. Since avian viruses either lack the viral regulatory gene HBx or encode a highly divergent form of HBx, the potential role of HBx in the development of HCC has been the subject of intense investigation. Accumulating evidence suggests that HBx possesses biological properties that are relevant to cell transformation, including the ability to induce apoptosis (Bouchard & Schneider, 2004) . However, the underlying molecular mechanism that links HBx to HCC development is not completely understood.
HBx has been reported to be localized to diverse subcellular compartments, ranging from the nucleus (Weil et al., 1999) to the cytoplasm (Dandri et al., 1996; Sirma et al., 1998; Su et al., 1998) and more recently to mitochondria (Henkler et al., 2001; Kim et al., 2007; McClain et al., 2007; Rahmani et al., 2000; Takada et al., 1999; Waris et al., 2001) . However, it has been difficult to detect HBx either in vivo or in vitro and only trace amounts of HBx have been detected in a woodchuck model (Dandri et al., 1996) . Given the different localization patterns and low abundance of HBx expression in cells, deciphering the actual role of HBx in a physiological context has been challenging. Initial studies characterized HBx as a transcriptional transactivator acting in the nucleus (Murakami, 2001) . In contrast, HBx acting in the cytoplasm was shown to induce activation of multiple signalling pathways such as Src kinase (Klein et al., 1999; Klein & Schneider, 1997) , Ras-Raf-MAPK (Benn & Schneider, 1994; Natoli et al., 1994) and NF-kB (Chirillo et al., 1996; Su & Schneider, 1996) . As such, the subcellular location and physiological role of HBx has been a longdebated issue (Bouchard & Schneider, 2004 ). 1992 ). The first insight into the critical role of HBx came from observations in a woodchuck model, in which it was demonstrated that HBx is required to establish persistent viral infection (Chen et al., 1993; Zoulim et al., 1994) . This in vivo finding was recapitulated successfully in the HepG2 cell line, but not in Huh7 cells, which explains the earlier failure to detect an HBx effect in Huh 7 cells (Melegari et al., 1998) . Specifically, using a 1.2 genome equivalent replicon construct, it was shown that HBx stimulates viral genome synthesis at a greater level than a replicon without HBx by an order of magnitude (Bouchard et al., 2001; Melegari et al., 1998; Zhang et al., 2004) .
It has remained unclear whether the subcellular localization of HBx is responsible for stimulation of viral genome replication. It was thought that the cytoplasmic function of HBx was largely responsible for HBx-mediated stimulation of viral genome replication, since only a minimal reduction in viral transcripts was observed in the absence of HBx (Klein et al., 1999) . This was supported by the finding that when HBx was engineered to include a nuclear localization signal (NLS-HBx), it failed to support viral genome replication (Klein et al., 1999) . Contrary to these observations, evidence has suggested that the stimulation of viral replication by HBx occurs primarily at the transcriptional level (Tang et al., 2005) . Another independent study reported a critical importance for nuclear HBx, in which it was shown that NLS-HBx stimulated viral genome replication, whereas nuclear export signal (NES)-HBx failed to do so (Leupin et al., 2005) . Therefore, controversy concerning the relative contribution of HBx to the stimulation of viral genome replication in two distinct cellular compartments remains.
To address this, we evaluated the relative contribution of both the nuclear and cytoplasmic forms of HBx on the stimulation of viral genome replication, and attempted to define the steps at which HBx contributes to this process. We demonstrated that both nuclear and cytoplasmic HBx contribute to the stimulation of genome replication. The data indicate that both nuclear and cytoplasmic HBx act primarily at the level of transcription, although the underlying mechanisms leading to stimulation differ.
METHODS
Cells and transfections. HepG2 cells were grown in Dulbecco's modified Eagle's medium (Gibco-BRL) supplemented with 10 % fetal bovine serum (Gibco-BRL) and 10 mg gentamicin ml
21
, at 37 uC/5 % CO 2 . Polyethylenimine (PEI) (25 kDa; Sigma-Aldrich) was employed for transfection as described previously (Ryu et al., 2008) , except that cells were incubated with a DNA-PEI complex overnight. Transfection efficiencies of 10-20 % were routinely obtained in HepG2 cells using this method.
HBV constructs. The 1.2-mer-wild-type (WT) replicon (containing 1.2 units of the HBV genome) was made as described previously (Guidotti et al., 1995; Melegari et al., 1998) . To create the HBx-null counterpart of the HBV 1.2-mer replicon, two ochre stop codons were introduced into a position immediately following the first and second AUG of the X-ORF, where C residues at nt 22 and 259 of X-ORF were substituted with a T residue, such that the amino acid residues encoded by the overlapping P-ORF remained unaltered. pCMV-HBx*, a FLAG-tagged HBx expression vector, was generated by inserting a fragment encoding X-ORF in-frame into the p3XFLAG-CMV-14 plasmid (Sigma). Re-targeting HBx constructs were made by inserting a fragment encoding either NLS or NES into the N terminus of the X-ORF of pCMV-HBx*. NLS was derived from SV40 Tantigen; NES was derived from HIV Rev. A HBV core promoter/ enhancer reporter construct, pHBV-Luc, was made as previously described (Tang et al., 2005) , with some modifications. Specifically, the fragment containing HBV enhancer I and enhancer II, as well as the basal core promoter derived from the 1.2-mer HBx-null construct, was inserted upstream of the luciferase ORF of pGL3-Basic plasmid (Promega).
Immunostaining. Immunostaining was performed as described previously (Cha et al., 2004) . HepG2 cells were transfected and 2 days post-transfection (p.t.), cells were fixed and stained with monoclonal anti-FLAG antibody (1 : 500; Sigma-Aldrich). Cells were visualized by fluorescence and confocal microscopy (Carl Zeiss). Mitochondria were stained with MitoTracker (Molecular Probes).
Southern blot analysis. Viral DNA from cytoplasmic capsids was isolated from HepG2 cells 4 days p.t. and Southern blot analysis was performed as described by Shin et al. (2004) . Briefly, the extracted viral DNA was separated by electrophoresis through a 1.3 % agarose gel in a 0.56 Tris/acetate-EDTA buffer and then transferred onto a nylon membrane. The nylon membrane was prehybridized and hybridized with a 32 P-labelled full-length HBV DNA probe in hybridization solution for 16 h at 65 uC. Images were obtained using the phosphoimager (BAS-2500; Fujifilm).
Western blot analysis. Western blot analysis was performed as described previously (Ryu et al., 2008) . Mouse anti-FLAG M2 antibody (1 : 5000; Sigma-Aldrich) was used to detect the FLAGtagged HBx protein.
Reporter assay. Four days p.t., cells were harvested and assayed using the luciferase reporter assay system (Promega) and a TD 20/20 Luminometer (Turner Design).
Extraction of viral RNA. Cells were harvested for RNA extraction 4 days p.t. as described previously (Jeong et al., 2000) , with some modifications. To reduce the variability between plates during RNA extraction, both capsid and total cytoplasmic fractions were isolated from a single plate. HepG2 cells were washed twice with cold HBS-EGTA buffer [2 mM HEPES (pH 7.5), 100 mM NaCl, 0.5 mM EGTA] and lysed in lysis buffer [50 mM Tris/HCl (pH 8.0), 1 mM EDTA, 1 % NP-40, 100 mM NaCl] containing 5 mM vanadyl ribonucleoside complexes (Fluka). Nuclei were removed by centrifugation. Half of the lysate was used to isolate total cytoplasmic RNA and the other half was used to isolate the capsid RNA. Capsids were collected by immunoprecipitation using anti-core antibody (DAKO). Briefly, cell lysate was mixed with anti-core antibody for 1 h at 4 uC. Protein G-Sepharose was added and the mixture was incubated for an additional 2 h at 4 uC. Samples were washed with lysis buffer and immunoprecipitates were collected by centrifugation. Total and capsid-associated RNA was extracted with Trizol (Gibco-BRL).
RNase protection analysis (RPA). RNA was analysed by RPA according to the manufacturer's protocol (Ambion). The riboprobe was derived from the core region (nt 1903-2140), as described previously (Ryu et al., 2008 Stimulation of HBV genome replication by HBx for 30 min at 37 uC. The digested products were separated on 5 % acrylamide-8 M urea gels. Images were obtained using the phosphoimager (BAS-2500; Fujifilm).
Statistical analysis. A two-tailed Student's t-test, assuming unequal variances, was used for all statistical analyses; a P value of ,0.05 was considered statistically significant.
RESULTS

Experimental strategy and subcellular localization of HBx
To define the contribution of HBx to viral infection, it is important to relate its multitude of functions to its subcellular localization. In particular, we were interested in defining how the subcellular localization of HBx relates to its ability to stimulate viral genome replication. To address this issue, we established an HBV replicon system that depends on HBx. We constructed a 1.2-mer HBV replicon construct (i.e. 1.2 genome equivalents), as previously reported (Guidotti et al., 1995; Melegari et al., 1998) . The HBx-null version of the plasmid (1.2-mer HBxnull) was made in parallel (Fig. 1a) . In addition, the HBx expression plasmid, pCMV-HBx*, was made, in which three tandem copies of the FLAG epitope were inserted at the C terminus of HBx (see Fig. 2a ).
To measure the extent by which HBx stimulates viral genome replication, HepG2 cells were transfected as indicated and the viral replication intermediates extracted from cytoplasmic nucleocapsid particles were analysed by Southern blot (Fig. 1b) . The data showed that relaxed-circular (RC) and double-strand linear (DL) DNA were abundant in cells transfected with the 1.2-mer-WT, as anticipated (Fig. 1b , lane 2). However, far less viral DNA was detected in 1.2-mer HBxnull-transfected cells (Fig. 1b, lane 3) , suggesting that HBx exerted a fivefold stimulatory effect on viral genome replication (Fig. 1c) . We complemented the HBx-null replicon by transfecting cells with three different amounts of the HBx expression plasmid pCMV-HBx*. The data indicated that HBx provided in trans successfully complemented the HBxnull replicon in yielding viral DNA replication intermediates (Fig. 1b, lanes 4-6) . Not surprisingly, the amount of viral DNA synthesized increased proportionally up to fourfold as the amount of transfected HBx DNA was increased (Fig. 1b, c) . Western blot analysis performed using anti-FLAG antibody showed that the amount of HBx protein increased accordingly with the amount of transfected DNA (Fig. 1b) . More importantly, an HBV replicon was established whose DNA replication depends on the HBx expression level in a linear manner (Fig. 1c) . In addition, the physiological relevance of our trans-complementation assay was substantiated, since HBx derived from the endogenous viral promoter fully rescued viral genome replication ( Supplementary Fig. S1 , available in JGV Online).
Cells transfected with three different amounts of the HBx expression plasmid pCMV-HBx* were analysed by indirect immunofluorescence. Immunostaining with anti-FLAG antibody indicated that HBx was confined to the nucleus when expressed at low levels, whereas it was detected predominantly in the cytoplasm when expressed at high levels. At medium levels, however, HBx was detectable in both the nucleus and cytoplasm (Fig. 1d) . Intriguingly, the data suggest that the subcellular localization of HBx is determined primarily by its abundance. Consistent with immunostaining data, biochemical fractionation of cells showed that the subcellular localization of HBx is primarily affected by its abundance (Supplementary Fig. S2 , available in JGV Online). Based on this result and the Southern blot data above, we concluded that HBx stimulates viral genome replication regardless of its subcellular localization.
Re-targeting variants of HBx
The data above indicate that (i) the subcellular localization of HBx was primarily influenced by its abundance (Fig. 1d ) and (ii) viral genome replication critically depends on HBx level (Fig. 1c) . Since the expression level of HBx affects its subcellular localization, it is difficult to relate subcellular localization to its impact on viral genome replication. To circumvent this problem, we re-targeted HBx to either the nucleus or the cytoplasm. HBx was tagged with either a nuclear localization signal (NLS-HBx*) or nuclear export signal (NES-HBx*) (Fig. 2a) . These plasmids were then transfected into HepG2 cells and the distribution of HBx was visualized by immunostaining and fluorescence microscopy. In addition, cells were co-stained with MitoTracker, a mitochondrial marker.
First, we examined cells that were transfected with a medium level (i.e. 1.8 mg per 100 mm plate) of the HBx expression plasmid (Fig. 2b) . Immunostaining with anti-FLAG antibody indicated that HBx was detected in both the nucleus and cytoplasm, consistent with the data in Fig. 1(d) . Mitochondrial association of HBx was detected in cells, where HBx was detected in both the nucleus and cytoplasm (Fig. 2b) . As predicted, NLS-HBx was confined to the nucleus, while NES-HBx was localized predominantly in the cytoplasm (Fig. 2b) . This distribution pattern was independent of its expression level (data not shown). In addition, the result showed that NES-HBx was largely associated with the mitochondria (Fig. 2b) .
Stimulation of viral genome replication by the re-targeted HBx
To determine the extent to which re-targeted HBx stimulates viral genome replication, HepG2 cells were transfected with an HBx-null replicon in addition to an HBx expression plasmid (Fig. 3a) . To preclude saturation of viral genome replication due to HBx overexpression, the amount of pCMV-HBx plasmid corresponding to medium levels shown in Fig. 1(b) was used for transfection. Southern blot analysis indicated that both NLS-and NES-HBx significantly stimulated viral DNA replication compared with the 1.2-mer HBx-null-transfected control (Fig. 3a, lane 3 versus 5 and 6 ). In fact, the amount of viral DNA appeared slightly reduced in cells transfected with NES-HBx relative to that in cells transfected with WT or NLS-HBx (Fig. 3a, lane 4 versus 5 and 6 ). However, quantitative estimation from five independent transfections revealed that the stimulation of viral genome replication by NLS-and NES-HBx was approximately fourfold greater than in HBx-null-transfected cells (Fig.   3c ). Western blot analysis indicated that the levels of both NLS-and NES-HBx proteins were comparable to those of WT (Fig. 3b) . Statistical analysis revealed that the ability to stimulate viral genome replication by NLS-HBx was not statistically significantly different to that of WT (i.e. P.0.05), while that of NES-HBx was slightly less than that of WT (i.e. P,0.05) (Fig. 3c) . Nonetheless, NES-HBx stimulated viral genome replication by approximately fourfold (Fig. 3a, lane 3 versus 6, and Fig. 3c) . Therefore, Fig. 1 . The subcellular localization of HBx is influenced primarily by its expression level. (a) Map of HBV replicon constructs used in this study. Schematic representation of the pregenomic RNA that is transcribed from each replicon construct is shown at the top, with two stem-loop structures (e) at both ends due to terminal redundancy (R) (Seeger et al., 2007) . The maps of two HBV replicon constructs are depicted below; the X-ORF region is expanded (open box) to show the modification made in each construct. The 1.2-mer HBx-null construct harbours two stop codons immediately following the first and second initiation codon of the X-ORF as a consequence of the change from C to T (bold). DR, Direct repeat. (b) Southern and Western blot analysis. HepG2 cells were transfected with 18 mg of the 1.2-mer-WT or 1.2-mer HBx-null construct, along with three different amounts of pCMV-HBx* [0.6 mg (L, low), 1.8 mg (M, medium) or 6.0 mg (H, high) per 100 mm plate]. Southern blot analysis (upper panel) was carried out as previously reported (Shin et al., 2004) . Cytoplasmic core particles were isolated as described in Methods. A restriction fragment representing one HBV genomic unit of 3.2 kb served as a size marker (SM). Three HBV replication intermediates are indicated to the right (filled arrows): relaxed circular (RC), double-strand linear (DL) and single-strand (SS) DNA. Western blot analysis (lower panel) was performed in parallel as described in Methods. . Two days p.t., cells were fixed and HBx was visualized with anti-FLAG monoclonal antibody (upper panels). Nuclei were counterstained with DAPI (lower panels).
Stimulation of HBV genome replication by HBx
we concluded that the stimulation of viral genome replication is linked to nuclear HBx and, to a lesser extent, cytoplasmic HBx, although their capacity for stimulation was modestly compromised relative to WT.
HBV promoter reporter assay
Given that the subcellular localization of NLS-HBx differs from that of NES-HBx, it is likely that the steps at which they stimulate viral genome replication are distinct from one another. To address this issue, we sought to measure the extent of transcriptional activation by re-targeted HBx. pCMV-HBx* contains three copies of the FLAG epitope at its C terminus. NLS-HBx* and NES-HBx* were generated by insertion of NLS and NES tags, which are indicated, into its N terminus. (b) Immunofluorescence of HBx in transfected HepG2 cells. HepG2 cells were transfected with the indicated DNA constructs. Two days p.t., cells were stained with MitoTracker (mitochondrial marker) and fixed. Immunostaining and counterstaining were performed with anti-FLAG monoclonal antibody and DAPI, respectively. Merge images show the superimposed images of HBx, DAPI and MitoTracker. Yellow colour indicates the overlap of green (HBx) and red (mitochondria). These images were visualized by using confocal microscopy. Thus, the HBV core promoter/enhancer-driven reporter assay was performed, as previously described but with some modifications (Raney et al., 1990; Tang et al., 2005) . In particular, to preclude the effect of the overlapping X-ORF, this was inactivated by introducing two stop codons into a position immediately downstream of the first and second AUG codons of X-ORF (Fig. 4a) , using a similar method to that shown in Fig. 1(a) . Thus, the impact of complementing HBx variants could be measured accurately in the absence of the overlapping X-ORF expression (see Discussion). Cells were transfected with the pHBVluciferase reporter construct along with HBx expression constructs. As anticipated, luciferase activity was enhanced up to fourfold by WT HBx (Fig. 4b) . Intriguingly, the reporter activity was enhanced approximately threefold by both NLS-and NES-HBx (Fig. 4b) . Overall, the extent of stimulation measured by the reporter assay largely paralleled that measured by Southern blot analysis (Fig.  3a, c) . The results suggested that HBx, regardless of its subcellular localization, stimulates viral genome replication by augmenting viral transcription.
Impact of HBx on encapsidation
A recent study reported that HBx facilitates encapsidation of the pregenomic RNA by five-to tenfold, to the extent that it could fully account for the impact of HBx on viral genome replication (Melegari et al., 2005) . To determine the extent to which HBx affects encapsidation of the pregenomic RNA, we examined viral pregenomic RNA by RPA. Cells were transfected with either the 1.2-mer-WT or 1.2-mer HBx-null construct along with the indicated HBx expression plasmids. Total and capsid-associated viral transcripts were isolated from the cytoplasm and were measured by RPA (Fig. 5a) . RPA of total cytoplasmic RNA revealed that the amount of pregenomic RNA from cells transfected with the 1.2-mer HBx-null plasmid was reduced by approximately fivefold relative to that of the 1.2-mer-WT construct (Fig. 5a , lane 2 versus 4, and Fig. 5b) . Importantly, this magnitude could account fully for the fivefold stimulatory effect of HBx on viral genome replication (Fig. 3a) . Thus, this result is consistent with the interpretation that HBx contributes to viral genome replication entirely at the transcriptional level. Next, we examined the impact of re-targeted HBx on viral pregenomic RNA accumulation. RPA data indicated that both NLS-and NES-HBx appeared to complement the 1.2-mer HBx-null construct to a similar extent (Fig. 5a, lanes 8  and 10) , a result that is consistent with their role at the transcriptional level.
We then assessed the impact of HBx on encapsidation. Encapsidation efficiency was assessed by measuring a fraction of capsid-associated pregenomic RNA relative to that detected in the total cytoplasmic fraction. This revealed that approximately 50 % of the pregenomic RNA in the cytoplasm was packaged in the 1.2-mer-WTtransfected cells (Fig. 5b) . Likewise, the encapsidation efficiency reached nearly 60 % in 1.2-mer HBx-nulltransfected cells (Fig. 5b) . Statistical analysis indicated that the encapsidation efficiency in the HBx-null-transfected cells was not significantly different from that in WT (i.e. P.0.05) (Fig. 5b) . This result is inconsistent with a previous report by Melegari et al. (2005) . However, the data parallel the above conclusion, in that HBx stimulates viral genome replication at the transcriptional level. Next, we measured the encapsidation efficiencies that were manifested by re-targeted HBx (Fig. 5a ). The estimation indicated that both NLS-and NES-HBx supported more than 60 % of encapsidation efficiency (Fig. 5c ). Statistical analysis indicated that encapsidation efficiencies obtained by either NLS-or NES-HBx were not significantly different from those of WT (i.e. P.0.05). Overall, the findings here clearly excluded the notion that HBx facilitates the encapsidation process.
DISCUSSION
By using two distinct experimental approaches, we clearly demonstrated that both nuclear and cytoplasmic HBx have the ability to stimulate viral genome replication. First, by transfecting increasing amounts of HBx expression plasmid, we were able to show that both nuclear HBx, when HBx was expressed at a lower level, and cytoplasmic HBx, when HBx was expressed at a higher level, stimulated viral genome replication to similar levels (Fig. 1) . Secondly, by using re-targeted HBx, we showed that both NLS-and NES-HBx similarly augmented viral genome replication to similar levels (Fig. 3) . The latter finding was further strengthened by the observation that both NLS-and NESHBx affected viral genome replication at the transcription level (Figs 4 and 5) .
The subcellular localization of HBx has been the subject of much controversy. The discrepancies between studies could be attributed to differences in experimental conditions, such as the expression vectors used for transfection and antibodies used for HBx detection. Indeed, variability in the ability of anti-HBx antibodies to detect HBx in tissue has been a prominent problem (Su et al., 1998) . To circumvent the known difficulties in detecting HBx, we used an HBx expression vector encoding HBx linked to three tandem FLAG epitopes (Figs 1a and 2a) . Concerns that the FLAG tag might alter the biological properties of HBx were ruled out, since both the FLAG-tagged and untagged HBx yielded comparable results with respect to three well-characterized properties of HBx: (i) transactivation of HBV core promoter, (ii) the activation of AP-1 and NF-kB promoters and (iii) the stimulation of viral genome replication (Figs 1b and 4b and data not shown). Furthermore, haemagglutinin-tagged HBx yielded comparable results with respect to subcellular localization ( Supplementary Fig. S3 , available in JGV Online) and stimulation of viral genome replication (data not shown).
Microscopic observation indicated that the subcellular localization of HBx primarily depended on its expression level (Fig. 1d) . Discrepancies in the literature regarding subcellular localization of HBx could simply be attributed to the wide variation in HBx expression level. The influence of the expression level of HBx on its subcellular localization was first noted by Henkler et al. (2001) , in which the authors found a correlation between the cytoplasmic localization of HBx and its abundant expression, as determined by comparing cells in a single plate. Our data, obtained by transfecting different amounts of the expression plasmid and determining localization, substantiate this (Fig. 1) . On the other hand, cytoplasmic localization of HBx was reported in in vivo studies, such as in hepatocytes in the woodchuck model (Dandri et al., 1996 (Dandri et al., , 1998 and in the livers of chronically infected patients (Su et al., 1998) . Due to the limit of sensitivity of various anti-HBx antibodies used in these reports, it could be argued that HBx would have been detected only in abundantly expressing cells, where HBx was localized predominantly in the cytoplasm.
In addition, HBx was found to be associated with mitochondria (Fig. 2b) . This is concordant with previous reports that also observed colocalization of HBx with mitochondria (Henkler et al., 2001; Kim et al., 2007; McClain et al., 2007; Rahmani et al., 2000; Takada et al., 1999; Waris et al., 2001) 2-mer-WT or 1.2-mer HBx-null construct, along with 1.8 mg (medium level) of HBx expression plasmid, as indicated. RNA extracted from the capsid (C) and total cytoplasmic (T) fractions was analysed. The RPA probe was derived from the C gene region for specific detection of the pregenomic RNA (arrowhead). (b) Quantification and encapsidation efficiency (%) estimated by comparing the amount of pregenomic RNA found in the capsid fraction to that found in the total cytoplasmic fraction. The value for the 1.2-mer (a, lane 2) was set to 100. A representative RPA of at least five experiments is shown. Statistical analysis indicated that encapsidation efficiency of the 1.2-mer HBx-null was not significantly different from that of the 1.2-mer-WT, since the P value for the null hypothesis was 0.634. (c) Quantification and encapsidation efficiency. The value for the 1.2-mer HBx-null construct complemented with WT HBx (a, lane 6) was set to 100. Statistical analysis indicated that encapsidation efficiencies manifested by the NLS-HBx* and NES-HBx* were not significantly different from those of HBx*, since the P values for the null hypothesis were 0.831 and 0.694, respectively.
On the other hand, two previous studies that utilized a similar re-targeting strategy reported conflicting findings regarding the functional location of HBx. For instance, NLS-HBx failed to support viral genome replication when Chang liver cells were used (Klein et al., 1999) , whereas Leupin et al. (2005) showed that by employing HepG2 cells, NLS-HBx supported viral genome replication to a level comparable to the WT. One possibility for this discrepancy could be attributable to the cell line that was used in the earlier study, in which activation of Src kinase, which is critical for the stimulation of viral genome replication, by HBx has not been observed (Klein et al., 1999; Klein & Schneider, 1997) . On the other hand, in contrast to our findings, Leupin et al. (2005) claimed that a cytoplasmically targeted HBx failed to support viral genome replication. It remains possible, however, that the particular variant of HBx that they used (NESGFPHBx) could be functionally defective, since it had an extraordinarily long N-terminal extension. Overall, we speculate that the discrepancies in the literature regarding the functional location of HBx are most likely attributable to the particular cell line (Klein et al., 1999) or HBx expression construct (Leupin et al., 2005) that was used. Thus, we concluded that both nuclear and cytoplasmic HBx functionally support the stimulation of viral genome replication. It remains to be seen whether the stimulation of viral genome replication by either nuclear or cytoplasmic HBx could be specifically blocked by inhibiting either of these regulatory proteins.
Another important issue that remains unresolved is the step at which HBx stimulates viral genome replication. Unexpectedly, the reporter assay indicated that both NLSand NES-HBx, albeit located in different cellular compartments, stimulated viral genome replication to a similar extent at the transcriptional level (Fig. 4b) . RPA data further corroborated that enhancement of the pregenomic RNA level by both NLS-and NES-HBx occurred at the transcriptional level (Fig. 5) . The notion that HBx stimulates viral genome replication at the level of transcription was further strengthened by a recent observation made in a mouse model (Keasler et al., 2007) . However, we did not observe an impact on encapsidation by HBx (Fig. 5) , in contrast to a recent study that showed that HBx enhanced encapsidation up to tenfold (Melegari et al., 2005) . The source of these experimental discrepancies remains unclear.
In this report, we extensively analysed the subcellular localization of HBx using three distinct methods: microscopy, biochemical fractionation and protein re-targeting.
The data presented here demonstrate the importance of the level of HBx expression on its compartmentalization within cells. One plausible scenario in the context of chronic infection is that HBx is localized predominantly in the nucleus during the early stage of viral infection and the subsequently enhanced HBx level, which is caused by either genetic alterations (host or virus) or inflammatory cytokines, during the late phase of chronic infection leads to cytoplasmic accumulation of HBx. We speculate that the enhanced HBx during the late phase of chronic infection might be linked to disease progression.
